Recommendations for symptom management in women with vulvar neoplasms after surgical treatment: An evidence-based guideline. (December 2016)

• Record Type: Journal Article
• Authors: Kobleder, Andrea; Raphaelis, Silvia; Glaus, Agnes; Fliedner, Monica; Mueller, Michael D.; Gafner, Dinah; Gehrig, Larissa; Senn, Beate
• Is Part Of: European journal of oncology nursing. Volume 25(2016)
• Page Start: 68
• Page End: 76
• Publication Date: 2016-12
• Subjects: Evidence-based guideline -- Vulvar cancer -- Vulvar intraepithelial neoplasia -- Symptoms and distress -- Self-management -- Symptom-management; Cancer -- Nursing -- Periodicals; Cancer -- Research -- Periodicals; Oncology -- Periodicals; Oncology Nursing -- Periodicals; Neoplasms -- nursing -- Periodicals; Cancer -- Soins infirmiers -- Périodiques; Cancer -- Recherche -- Périodiques; Cancérologie -- Périodiques; Verpleegkunde; Kanker; Cancer -- Nursing; Cancer -- Research; Oncology; Electronic journals; Periodicals; Electronic journals; 616.9940231
• DOI: 10.1016/j.ejon.2016.10.003
• Languages: English
• ISSNs: 1462-3889

Abstract

Abstract: Purpose: To develop an evidence-based guideline for nurses and other health care professionals involved in pre- and postsurgical care of women with vulvar cancer (VC) or vulvar intraepithelial neoplasia (VIN). Methods: This evidence-based guideline was developed according to six domains of the methodological framework AGREE II. Literature research with focus on cancer care, symptom management and self-management/counselling was conducted from April to August 2013 in the databases CINAHL, Cochrane Library, PsycINFO, PubMed as well as in 14 international guideline databases. Interdisciplinary experts (n = 14) were involved in the development of the guideline from December 2013 to January 2014. This guideline is currently tested in the WOMAN-PRO II RCT (Clinical Trial No: NCT01986725). Results: For the definition of recommendations, five guidelines, one meta-analysis, two systematic reviews and two randomized controlled trials were included. In total, 24 recommendations were formulated to answer 22 clinical questions based on patients' perspective and experts' opinion. Evidence ranged from 3.5 to 5 (3.5 = weak evidence and/or clinical relevance, 5 = best evidence and/or clinical relevance). The recommendations were subsumed under different themes regarding physical, psychological and psychosocial aspects. Conclusions: The clinical practice guideline developed in this study firstly provides recommendations for symptom management issues focusing on self-management interventions for women with VC or VIN. As an interdisciplinary guideline it should be used in addition to the existing medical guideline in the German speaking context. Highlights: To date, there are no evidence-based recommendations focusing on the most prevalent symptoms in women with vulvar neoplasms. This article presents the development of an evidence-based guideline for symptom management in women with vulvar neoplasms. The guideline should be used in addition to the existing medical guideline in the German speaking context.